Article info

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

Authors

  1. Correspondence to Dr Howard L Kaufman; HLKaufman{at}mgh.harvard.edu
View Full Text

Citation

Gastman B, Agarwal PK, Berger A, et al
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

Publication history

  • Accepted October 12, 2020
  • First published November 16, 2020.
Online issue publication 
November 16, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.